Difference between revisions of "Team:KU Leuven/Parts"

 
(27 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
{{KU_Leuven}}
 
{{KU_Leuven}}
 
<html>
 
<html>
<div class="puzzle" id="parts">
+
<style type="text/css">
<div class="jumbotron">
+
       
<div class="container">
+
        h4 {
<h1>Parts</h1>
+
            margin-bottom: 10px;
<p>Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod
+
        }
tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
+
        .background{
quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
+
            background:url(https://static.igem.org/mediawiki/2017/c/cb/KU_Leuven_Homepage2.png);
consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
+
            position: initial;
cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
+
            background-size: 100%;
proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>
+
            padding: 0 10px 0 10px;
</div>
+
        }
</div>
+
 
<div class="container">
+
        #grad {
<div class="column full_size">
+
    background: -webkit-linear-gradient(#faebd7,#faeddb,#fbefdf,#fbf1e3,#fcf3e7,#fcf5eb,#fdf7ef,#f2f2f2); /* Safari 5.1-6.0 */
<h1>Parts</h1>
+
    background: -o-linear-gradient((#faebd7,#faeddb,#fbefdf,#fbf1e3,#fcf3e7,#fcf5eb,#fdf7ef,#f2f2f2)); /* Opera 11.1-12.0 */
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
    background: -moz-linear-gradient((#faebd7,#faeddb,#fbefdf,#fbf1e3,#fcf3e7,#fcf5eb,#fdf7ef,#f2f2f2)); /* Firefox 3.6-15 */
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
    background: linear-gradient((#faebd7,#faeddb,#fbefdf,#fbf1e3,#fcf3e7,#fcf5eb,#fdf7ef,#f2f2f2)); /* Standard syntax */
</div>
+
    }
<div class="column half_size">
+
    p.head::first-letter {
<div class="highlight">
+
            color: #cc3333;
<h5>Note</h5>
+
            font-size: 40px;
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
    }
</div>
+
       
</div>
+
        p {
<div class="column half_size">
+
          text-align:justify;
<h5>Adding parts to the registry</h5>
+
          font-size: 20px;
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
        }
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
 
</div>
+
 
<div class="column half_size">
+
#images{
<h5>What information do I need to start putting my parts on the Registry?</h5>
+
    text-align:center;
<p>The information needed to initially create a part on the Registry is:</p>
+
    margin:50px auto;
<ul>
+
}
<li>Part Name</li>
+
#images a{
<li>Part type</li>
+
    margin:0px 20px;
<li>Creator</li>
+
    display:inline-block;
<li>Sequence</li>
+
    text-decoration:none;
<li>Short Description (60 characters on what the DNA does)</li>
+
font-size: 10px;
<li>Long Description (Longer description of what the DNA does)</li>
+
    color:black;
<li>Design considerations</li>
+
}
</ul>
+
 
<p>
+
        </style>
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
+
       
</div>
+
<script>$('#groupparts').load('/cgi/api/groupparts.cgi', { t:'iGEM17', g:'KU_Leuven' },function(){ $('#groupparts .tablesorter').tablesorter();} );
<div class="column half_size">
+
        </script>
<h5>Inspiration</h5>
+
 
<p>We have a created a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
+
            <div id="grad">
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
+
                   
<ul>
+
                        <br>
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
+
                   
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
+
                        <div class="background">
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
+
                            <h1 style="text-align:center; padding: 30px; font-size:50px; color: white;">Parts</h1>
</ul>
+
                                <p class="head" style="text-align:center;color: white; padding: 10px 10px 60px 10px; font-size:15px;">We have designed several new biobricks related to electrophysiology, which will enable future teams to develop novel projects in this field. They are ion channels, adapted to conform to the biobrick standard. </p>
</div>
+
                       
<div class="column full_size">
+
                        </div>
<h5>Part Table </h5>
+
                    <br>
<p>Please include a table of all the parts your team has made during your project on this page. Remember part characterization and measurement data must go on your team part pages on the Registry. </p>
+
 
<div class="highlight">
+
 
</html>
+
                    <div class="container">
<groupparts>iGEM17 KU_Leuven</groupparts>
+
                   
<html>
+
                        <p class="head" style="text-align:justify; padding: 0px 50px 0px 50px;">
</div>
+
<center>For our project, ion channels were crucial. This is why we added four new ion channel-biobricks to the registry. You can read more about them on this page, or on the registry pages themselves.</center>
</div>
+
                          </p>
</div>
+
 
</div>
+
<div id="images">
</div>
+
    <a>
 +
        <img src="https://static.igem.org/mediawiki/2017/7/7e/Cell_hERG.png"> <img src="https://static.igem.org/mediawiki/2017/4/48/Cell_Kir.png">  
 +
        <div class="caption">On the left, we show the system we developed: A combination of HCN, hERG and α1G channels lead to oscillating cells. Based on our model, we suspected that the characteristics of these ion channels were crucial for our system. Therefore, we made an alternative system, where the hERG channel was replaced by another potassium channel, Kir2.1. As expected, the latter system did not show oscillations.</div>
 +
    </a>
 +
</div>
 +
 
 +
 
 +
    <div id="column1" style="float:left; text-align:justify; margin:10px; margin-bottom: 20px; width:45%;">
 +
    <center><b>Biobrick 1: mHCN2</b></center> 
 +
<i>Hyperpolarization-activated cyclic nucleotide–gated</i> (HCN) channels are a family of ion channels responsible for the generation of rhythmic activity in heart and nerve cells. Consequently, they are often nicknamed pacemaker channels. They show several unique characteristics: first of all, the channels are opened in response to hyperpolarisation instead of depolarisation. Furthermore, they are not completely selective for K<sup>+</sup>-ions, and as a result, there is a small Na<sup>+</sup> inward current which causes a slow depolarisation of the membrane, the so-called funny current or pacemaker depolarisation. These attributes cause the particular rhythmic behaviour of cells containing HCN channels, and as a result, an HCN channel is vital for our project.<br>
 +
In our project, we have created a biobrick based on the HCN2 isoform found in mice. The gene has been adapted to conform to the biobrick standard, meaning that several prohibited restriction sequences have been deleted by silent mutations. Furthermore, we have lowered the GC content of the protein, to enable production of the gene as an IDT gBlock for use in our and in future projects. <br> More information can be found  <a href="http://parts.igem.org/Part:BBa_K2263000">on the registry page.</a>  
 +
</div>
 +
 
 +
    <div id="column2" style="float:right; text-align:justify;margin:10px; margin-bottom: 20px; width:45%;">
 +
    <center><b>Biobrick 2: hERG</b></center>
 +
Another gene that has played a major role in our project is the <i>human Ether-à-go-go-Related Gene</i>, also known as hERG and, alternatively, as <i>KCNH2</i>. Like HCN, it is associated with the rhythm generated in natural sinus node cells. It encodes the K<sup>+</sup>-channel responsible for the repolarisation during the cardiac action potential. Furthermore, the hERG-encoded protein K<sub>v</sub>11.1 is of great medical and pharmaceutical importance, as inhibition of this protein is associated with the dangerous long QT syndrome, which may result in fainting, seizures and even sudden death. Therefore, hERG inhibition is a major antitarget in drug development, and all drugs have to be tested for hERG inhibition in early development.<br>
 +
We have created a biobrick based on the hERG gene, which has allowed us to replicate the sinus rhythm in HEK-293 cells. The biobrick has been developed based on the human mRNA isoform 1 sequence, which we have adapted to conform to the biobrick standard. In order to achieve this standard, multiple illegal restriction sites have been removed by silent mutations. We think this biobrick might be useful for future projects in the field of electrophysiology, but also for projects with a pharmaceutical aspect, as testing for hERG inhibition is an important aspect of drug development.
 +
<br> More information can be found  <a href="http://parts.igem.org/Part:BBa_K2263001">on the registry page.</a>  
 +
</div>
 +
 
 +
 
 +
    <div id="column1" style="float:left; text-align:justify; margin:10px; width:45%;">
 +
    <center><b>Biobrick 3: Kir2.1</b></center>  
 +
Kir2.1 is an inwardly rectifying potassium channel, encoded by the <i>kcnj2</i> gene. This ion channel is an interesting target for many interesting studies, as it has already been shown that Kir2.1 influences the electrophysiological properties when expressed in HEK-293 cells, resulting in a stable membrane potential of approximately -70mV, instead of the -30 to -40 mV typically found in non-transfected cells.<br>
 +
In our project, we used a model to indicate which ion channels could result in the oscillating system we present in the HEKcite project. To verify that we could not just use any ion channel, we made an analog system using Kir2.1. As expected, this system did not result in oscillation, which demonstrated the importance of our model. <br>
 +
This biobrick has been designed based on the mRNA sequence of the <i>kcnj2</i> gene found in mice. In our design, we have removed several forbidden restriction sites using silent mutations.
 +
<br> More information can be found <a href="http://parts.igem.org/Part:BBa_K2263002">on the registry page.</a>  
 +
</div>
 +
 
 +
    <div id="column4" style="float:right; text-align:justify;margin:10px;width:45%;">
 +
    <center><b>Biobrick 4: α1G</b></center>
 +
α1G, which is also known as CACNA1G or Ca<sub>v</sub>3.1, is the α1G subunit of the calcium voltage-gated channel. In our system, it is functional as a depolarising channel which allows the electrophysiological oscillations to occur. Furthermore, its functionality as a calcium channel allowed us to visualise a rhythm using calcium imaging in one of our earliest experiments. <br>
 +
Even though we were excited to deliver an α1G biobrick to the depository, we have unfortunately been unable to adapt and clone this ion channel to follow the biobrick standards. We suspect these troubles are largely the result of the large size of this gene, as it is almost 7000 nucleotides in length.
 +
<br> More information can be found  <a href="http://parts.igem.org/Part:BBa_K2263003">on the registry page.</a>  
 +
</div>
 +
</div>
 +
 
 +
<div class="container">
 +
<br>
 +
During our project, we used all ion channels in pIRES vectors. These are mammalian expression vectors, followed by an internal ribosome entry site (IRES) and a fluorescent marker. In such vectors, the part and the marker are transcribed at the same time, but translated independently. In such a system, the marker indicates that the part is transcribed in the cell, but they are not physically linked. This is beneficial, as a linked marker protein may affect or hinder the protein function.  
 +
<br><br>
 +
 
 +
<center>All information is summarised in the following table:
 +
 
 +
</div>
 +
 
 +
 
 +
       
 
</html>
 
</html>
 +
<center><groupparts>iGEM17 KU_Leuven</groupparts></center>
 
{{KU_Leuven_footer}}
 
{{KU_Leuven_footer}}

Latest revision as of 23:35, 1 November 2017


Parts

We have designed several new biobricks related to electrophysiology, which will enable future teams to develop novel projects in this field. They are ion channels, adapted to conform to the biobrick standard.


For our project, ion channels were crucial. This is why we added four new ion channel-biobricks to the registry. You can read more about them on this page, or on the registry pages themselves.

Biobrick 1: mHCN2
Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels are a family of ion channels responsible for the generation of rhythmic activity in heart and nerve cells. Consequently, they are often nicknamed pacemaker channels. They show several unique characteristics: first of all, the channels are opened in response to hyperpolarisation instead of depolarisation. Furthermore, they are not completely selective for K+-ions, and as a result, there is a small Na+ inward current which causes a slow depolarisation of the membrane, the so-called funny current or pacemaker depolarisation. These attributes cause the particular rhythmic behaviour of cells containing HCN channels, and as a result, an HCN channel is vital for our project.
In our project, we have created a biobrick based on the HCN2 isoform found in mice. The gene has been adapted to conform to the biobrick standard, meaning that several prohibited restriction sequences have been deleted by silent mutations. Furthermore, we have lowered the GC content of the protein, to enable production of the gene as an IDT gBlock for use in our and in future projects.
More information can be found on the registry page.
Biobrick 2: hERG
Another gene that has played a major role in our project is the human Ether-à-go-go-Related Gene, also known as hERG and, alternatively, as KCNH2. Like HCN, it is associated with the rhythm generated in natural sinus node cells. It encodes the K+-channel responsible for the repolarisation during the cardiac action potential. Furthermore, the hERG-encoded protein Kv11.1 is of great medical and pharmaceutical importance, as inhibition of this protein is associated with the dangerous long QT syndrome, which may result in fainting, seizures and even sudden death. Therefore, hERG inhibition is a major antitarget in drug development, and all drugs have to be tested for hERG inhibition in early development.
We have created a biobrick based on the hERG gene, which has allowed us to replicate the sinus rhythm in HEK-293 cells. The biobrick has been developed based on the human mRNA isoform 1 sequence, which we have adapted to conform to the biobrick standard. In order to achieve this standard, multiple illegal restriction sites have been removed by silent mutations. We think this biobrick might be useful for future projects in the field of electrophysiology, but also for projects with a pharmaceutical aspect, as testing for hERG inhibition is an important aspect of drug development.
More information can be found on the registry page.
Biobrick 3: Kir2.1
Kir2.1 is an inwardly rectifying potassium channel, encoded by the kcnj2 gene. This ion channel is an interesting target for many interesting studies, as it has already been shown that Kir2.1 influences the electrophysiological properties when expressed in HEK-293 cells, resulting in a stable membrane potential of approximately -70mV, instead of the -30 to -40 mV typically found in non-transfected cells.
In our project, we used a model to indicate which ion channels could result in the oscillating system we present in the HEKcite project. To verify that we could not just use any ion channel, we made an analog system using Kir2.1. As expected, this system did not result in oscillation, which demonstrated the importance of our model.
This biobrick has been designed based on the mRNA sequence of the kcnj2 gene found in mice. In our design, we have removed several forbidden restriction sites using silent mutations.
More information can be found on the registry page.
Biobrick 4: α1G
α1G, which is also known as CACNA1G or Cav3.1, is the α1G subunit of the calcium voltage-gated channel. In our system, it is functional as a depolarising channel which allows the electrophysiological oscillations to occur. Furthermore, its functionality as a calcium channel allowed us to visualise a rhythm using calcium imaging in one of our earliest experiments.
Even though we were excited to deliver an α1G biobrick to the depository, we have unfortunately been unable to adapt and clone this ion channel to follow the biobrick standards. We suspect these troubles are largely the result of the large size of this gene, as it is almost 7000 nucleotides in length.
More information can be found on the registry page.

During our project, we used all ion channels in pIRES vectors. These are mammalian expression vectors, followed by an internal ribosome entry site (IRES) and a fluorescent marker. In such vectors, the part and the marker are transcribed at the same time, but translated independently. In such a system, the marker indicates that the part is transcribed in the cell, but they are not physically linked. This is beneficial, as a linked marker protein may affect or hinder the protein function.

All information is summarised in the following table:

<groupparts>iGEM17 KU_Leuven</groupparts>